| Literature DB >> 36207709 |
Demisew Amenu Sori1, Stephan Bretones2, Georges Mellier3, Bertrand de Rochambeau2.
Abstract
BACKGROUND: Pelvic organ prolapse (POP) affects about half of the women and affects their quality of life. The current study is, therefore, aimed at determining the prevalence and surgical outcomes of severe stage POP at Jimma University medical center from November 2016 to May 2018.Entities:
Keywords: Colposuspension; Pelvic organ prolapse; Simplified pelvic organ prolapse quantification (S-POPQ); Surgical outcome
Mesh:
Year: 2022 PMID: 36207709 PMCID: PMC9540999 DOI: 10.1186/s12905-022-01992-8
Source DB: PubMed Journal: BMC Womens Health ISSN: 1472-6874 Impact factor: 2.742
Socio-demographic characteristics and obstetric variables of anterior vaginal wall prolapse in JUMC from Nov 1, 2016, to March 31, 2018
| Variable | Number (N = 92) | Percent | |
|---|---|---|---|
| Age in years | 20–29 | 7 | 7.6 |
| 30–39 | 19 | 20.7 | |
| 40–49 | 23 | 25.0 | |
| 50–59 | 23 | 25.0 | |
| ≥ 60 | 20 | 21.7 | |
| Parity (current) | ≤ I | 4 | 4.3 |
| II-IV | 28 | 30.4 | |
| ≥ V | 60 | 65.2 | |
| Marital status* (N = 87) | Single | 7 | 7.6 |
| Currently married | 61 | 66.3 | |
| Widowed | 18 | 19.6 | |
| Divorced /separated | 1 | 1.1 | |
| Residence | Urban | 27 | 29.3 |
| Rural | 65 | 70.7 | |
| Number of living children | ≤ 1 | 8 | 8.7 |
| 2–4 | 38 | 41.3 | |
| ≥ 5 | 46 | 50.0 | |
| Duration of AVWP with symptoms in years (median = 2.8 years) | ≤ 5 | 73 | 79.3 |
| 6–10 | 13 | 14.1 | |
| > 10 | 6 | 6.5 | |
| Do you have urinary incontinence? | Yes (SUI) | 3 | 3.3 |
| No | 89 | 96.7 | |
| Are you sexually active? (N = 56) | Yes | 56 | 60.9 |
| No | 36 | 39.1 | |
| Reasons for not sexually active (N = 36) | No partner | 17 | 47.2 |
| No interest | 16 | 44.4 | |
| Urinary incontinence /bulge | 3 | 8.3 | |
Asterisk shows the different number of study subjects for the variables
Risk factors of anterior vaginal wall prolapse (AVWP) in JUMC from Nov 1, 2016, to March 31, 2018
| Risk factors of AVWP | Number (N = 92) | Percent | |
|---|---|---|---|
| Mode of delivery | Vaginal | 92 | 100.0 |
| Chronic medical illnesses (N = 14) | Yes | 14 | 15.2 |
| No | 78 | 84.8 | |
| Type of Chronic medical illnesses | Asthma | 1 | 1.1 |
| Diabetes | 2 | 2.2 | |
| Hypertension | 10 | 10.9 | |
| HIV/AIDS | 1 | 1.1 | |
| Is the woman Menopause when she develops AVWP? | Yes | 51 | 55.4 |
| No | 41 | 44.6 | |
| Duration in menopause when in years (range = 1–20) | ≤ 5 | 18 | 19.6 |
| 6–10 | 15 | 16.3 | |
| > 10 | 18 | 19.6 | |
| Previous surgery was done (hysterectomy and or surgery for POP) | Yes | 4 | 4.3 |
| No | 88 | 95.7 | |
| Type of previous surgery | SSLF without hysterectomy (Richardson) | 1 | 25.0 |
| VH + AC + PC | 1 | 25.0 | |
| VH + AC | 2 | 50.0 | |
*VH= vaginal hysterectomy, AC= anterior colporrhaphy, PC= posterior colporrhaphy
Fig. 1The combined stage of POP before surgery in JUMC from November 1, 2016, to March 31, 2018. CHR: C = Anterior vaginal wall prolapse (AVWP), H = Apical prolapse, R = Posterior vaginal wall prolapse (PVWP)
Stages of pelvic organ prolapses using Simplified Pelvic Organ Prolapse Quantification (S-POPQ) and its treatment in JUMC from Nov 1, 2016, to March 31, 2018
| Variables | Number (N = 92) | Percent | |
|---|---|---|---|
| Anterior vaginal wall prolapse | Stage 2 | 6 | 6.5 |
| Stage 3 | 37 | 40.2 | |
| Stage 4 | 49 | 53.3 | |
| Apical prolapse | Stage 1 | 1 | 1.1 |
| Stage 2 | 5 | 5.4 | |
| Stage 3 | 44 | 47.8 | |
| Stage 4 | 42 | 45.7 | |
| Posterior vaginal wall prolapse | Stage 1 | 8 | 8.7 |
| Stage 2 | 31 | 33.7 | |
| Stage 3 | 25 | 27.2 | |
| Stage 4 | 28 | 30.4 | |
| The final stage of the prolapse | Stage 3 | 31 | 33.7 |
| Stage 4 | 61 | 66.3 | |
| Type of pelvic organ prolapse surgery | Anterior colporrhaphy | 72 | 78.3 |
| Anterior colporrhaphy with colposuspension | 54 | 58.7 | |
| Vaginal apical treatment | 83 | 90.2 | |
| Posterior colporrhaphy | 78 | 84.8 | |
| Rectal anterior plication | 7 | 7.6 | |
| Perineorrhaphy | 80 | 87 | |
| Colpohysterectomy with posterior myorrhaphy (Roulhier) | 9 | 9.8 | |
| Type of vaginal apical treatment (N = 82) | SSLF without hysterectomy (Richardson) | 10 | 12 |
| SSLF (Richter) | 33 | 39.8 | |
| Uterosacral ligament | 40 | 48.2 | |
| Type of anesthesia | Spinal | 89 | 96.7 |
| General | 3 | 3.3 | |
| Duration of surgery in minutes | = < 60 | 7 | 7.6 |
| 61–120 | 51 | 55.4 | |
| 121–180 | 32 | 34.8 | |
| > 180 | 2 | 2.2 | |
| Duration of postoperative bladder catheterization in hours | ≤ 48 | 77 | 83.7 |
| > 48 | 15 | 16.3 | |
Surgical outcomes of pelvic organ prolapses managed in JUMC from Nov 1, 2016, to March 31, 2018
| Variables | Number (N = 92) | Percent | |
|---|---|---|---|
| Surgery related complications | Yes | 8 | 8.7 |
| No | 84 | 91.3 | |
| Types of complications (the same patient can have more complications) [ | Bladder injury | 4 | 50 |
| Rectal injury | 1 | 12.5 | |
| Urinary retention | 3 | 37.5 | |
| Hemorrhage during SSLF | 3 | 37.5 | |
| Stage of AVWP at discharge | Stage 0 | 72 | 78.26 |
| Stage 1 | 16 | 17.39 | |
| Stage 2 | 4 | 4.35 | |
| Stage of apical prolapse at discharge | Stage 0 | 81 | 88.04 |
| Stage 1 | 11 | 11.96 | |
| Stage of PVWP at discharge | Stage 0 | 92 | 100.0 |
| The final stage of the prolapse at discharge | Stage 0 | 72 | 78.26 |
| Stage 1 | 16 | 17.39 | |
| Stage 2 | 4 | 4.35 | |
| Symptoms at discharge | No | 92 | 100.0 |
| Follow up visit at 3 months | Yes | 20 | 78.26 |
| No | 72 | 70.3 | |
| Stage of AVWP (N = 20) | ≤ Stage 0 | 18 | 90.0 |
| Stage 1 | 2 | 10.0 | |
| Stage of apical prolapse(N = 20) | ≤ stage 0 | 16 | 80.0 |
| Stage 1 | 4 | 20.0 | |
| Stage of PVWP | ≤ stage 0 | 20 | 100.0 |
| The final stage of POP | stage 0 | 16 | 80.0 |
| Stage 1 | 2 | 10.0 | |
| Stage 2 | 2 | 10.0 | |
| Symptoms at 3 months [ | No | 20 | 100.0 |